Definition, classification and diagnosis of fibromyalgia syndrome;Definition, klassifikation und diagnose des fibromyalgiesyndroms

Schmerz

Volumn 22, Issue 3, 2008, Pages 255-266

  Eich, W ^a,k   Hauser W ^b   Friedel, E ^c   Klement, A ^d   Herrmann, M ^d   Petzke, F ^e   Offenbacher M ^f   Schiltenwolf, M ^g   Sommer, C ^h   Tolle T ⁱ   Henningsen, P ^j  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b KLINIKUM SAARBRÜCKEN   (Germany)

^c Fibromyalgie Zentrum Bad Bocklet

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

^g Universitätsklinik Schlierbacher

^h UNIVERSITY OF WÜRZBURG   (Germany)

ⁱ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^j TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^k Psychosomatische Klinik Baden Baden

more..

Author keywords

Chronic widespread pain (CWP); Classification; Definition; Diagnosis; Fibromyalgia syndrome (FMS); Guidelines

Indexed keywords

CHRONIC PAIN; CLINICAL PRACTICE; COMORBIDITY; DISEASE CLASSIFICATION; EVIDENCE BASED MEDICINE; FIBROMYALGIA; GERMANY; HEALTH CARE ORGANIZATION; HUMAN; PREVALENCE; PROGNOSIS; REVIEW;

EID: 44649111823     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00482-008-0671-7     Document Type: Review

References (99)

1. Aaron LA, Bradley LA, Alarcon GS et al. (1996) Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum 39: 436-445
2. Aaron LA, Bradley LA, Alarcon GS et al. (1997) Perceived physical and emotional trauma as precipitating events in fibromyalgia. Associations with health care seeking and disability status but not pain severity. Arthritis Rheum 40: 453-460
3. Aaron L, Buchwald D (2003) Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions. Best Pract Res Clin Rheumatol 17: 563-574
4. Aaron LA, Buchwald D (2001) Fibromyalgia and other unexplained clinical conditions. Curr Rheumatol Rep 3: 116-121
5. Al-Allaf AW, Ottewell L, Pullar T (2002) The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2-4 years' follow-up. Clin Rheumatol 21: 472-477
6. Alexander RW, Bradley LA, Alarcon GS et al. (1998) Sexual and physical abuse in women with fibromyalgia: association with outpatient health care utilization and pain medication usage. Arthritis Care Res 11: 102-115
7. Andersson HI, Ejlertsson G, Leden I, Rosenberg C (1996) Characteristics of subjects with chronic pain, in relation to local and widespread pain report. A prospective study of symptoms, clinical findings and blood tests in subgroups of a geographically defined population. Scand J Rheumatol 25: 146-154
8. Baumgartner E, Finckh A, Cedraschi C, Vischer TL (2002) A six year prospective study of a cohort of patients with fibromyalgia. Ann Rheum Dis 61: 644-645
9. Bengtsson A, Backman E, Lindblom B, Skogh T (1994) Long term follow-up of fibromyalgia patients: Clinical symptoms, muscular function, laboratory tests - an eight year comparison study. J Musculoskeletal Pain 2: 67-80
10. Bergman S, Herrstrom P, Jacobsson LT, Petersson IF (2002) Chronic widespread pain: a three year followup of pain distribution and risk factors. J Rheumatol 29: 818-825
11. Bernatsky S, Dobkin PL, De Civita M, Penrod JR (2005) Co-morbidity and physician use in fibromyalgia. Swiss Med Wkly 135: 76-81
12. Biewer W, Conrad I, Häuser W (2004) Fibromyalgiesyndrom. Schmerz 18: 118-124
13. Boonen A, van den Heuvel R, van Tubergen A et al. (2005) Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis. Ann Rheum Dis 64: 396-402
14. Burckhardt CS, Goldenberg D, Crofford L et al. (2005) Guideline for the management of fibromyalgia syndrome pain in adults and children. APS Clinical Practice Guidelines Series No 4. American Pain Society, Glenview
15. Clauw D, Crofford LJ (2003) Chronic widespread pain and fibromyalgia: what we know and what we need to know. Best Pract Res Clin Rheumatol 17: 685-701
16. Croft P, Rigby AS, Boswell R et al. (1993) The prevalence of chronic widespread pain in the general population. J Rheumatol 20: 710-713
17. Croft PR, Schollurn J, Süman AJ (1994) Population study of tender point counts and pain as evidence of fibromyalgia. BMJ 309: 696-699
18. Croft PR, Burt J, Schollum J (1996) More pain, more tender points: is fibromyalgia just one end of a continuous spectrum? Ann Rheum Dis 55: 482-485
19. Deutsches Institut für medizinische Dokumentation und Information (DIMDI) (2006) ICD 10-GM. Version 2006. Internationale Statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme, 10. Revision - German modification. http://www.dimdi.de/static/de/klassi/diagnosen/icd10/ index.htm
20. Dobkin PL, De Civita M, Bernatsky S et al. (2003) Does psychological vulnerability determine health-care utilization in fibromyalgia? Rheumatology (Oxford) 42: 1324-1331
21. Dobkin PL, De Civita M, Abrahamowicz M et al. (2006) Predictors of health status in women with fibromyalgia: a prospective study. Int J Behav Med 13: 101-108
22. Donner-Banzhoff N, Maisel P, Baum E, Dörr C (2005) DEGMA-Leitlinie 2: Müdigkeit. http://www.degam.de/leitlinien/LL_muede_netz.pdf
23. Doron Y, Peleg R, Peleg A et al. (2004) The clinical and economic burden of fibromyalgia compared with diabetes mellitus and hypertension among Bedouin women in the Negev. Fam Pract 21: 415-419
24. Evers S, Göbel H (2003) Die deutschsprachige Übersetzung der 2. Auflage der Kopfschmerzklassifikation der International Headache Society. Nervenheilkunde 22: 531-670
25. Felson DT, Goldenberg DL (1986) The natural history of fibromyalgia. Arthritis Rheum 29: 1522-1526
26. Forseth KO, Forre O, Gran JT (1999a) A 5.5 year prospective study of self-reported musculoskeletal pain and of fibromyalgia in a female population: significance and natural history. Clin Rheumatol 18: 114-121
27. Forseth KO, Husby G, Gran JT, Forre O (1999b) Prognostic factors for the development of fibromyalgia in women with self-reported musculoskeletal pain. A prospective study. J Rheumatol 26: 2458-2467
28. Gran JT (2003) The epidemiology of chronic generalized musculoskeletal pain. Best Pract Res Clin Rheumatol 17: 547-561
29. Gralow I (2004) Ist die Fibromyalgie eine Krankheit? - Contra. Dtsch Med Wochenschr 129: 1337
30. Granges G, Zilko P, Littlejohn GO (1994) Fibromyalgia syndrome: assessment of the severity of the condition 2 years after diagnosis. J Rheumatol 21: 523-529
31. Hagen KB, Bjørndal A, Uhlig T, Kvien TK (2000) A population study of factors associated with general practitioner consultation for non-inflammatory musculoskeletal pain. Ann Rheum Dis 59: 788-793
32. Harth M, Nieslon RW (2007) The fibromyalgia tender points: use them or lose them? A brief review of the controversy. J Rheumatol 34: 914-922
33. Häuser W, Türp JC, Lempa M et al. (2004) Funktionelle somatische Schmerzsyndrome - Nomenklatur. Schmerz 18: 98-103
34. Häuser W (2005) Fibromyalgia in the legal procedures of the german sozialgericht - psychosocial risk factors and predictors of health care utilization. Psychother Psychosom Med Psychol 55: 72-78
35. Häuser W, Bernardy K, Arnold B (2006a) Das Fibromyalgiesyndrom - eine somatoforme Schmerzstörung? Schmerz 20: 128-139
36. Häuser W, Wilhelm R, Klein W, Zimmer C (2006b) Causal illness attributions and healthcare utilization in fibromyalgia syndrome. Schmerz 20: 119-127
37. Häuser W, Musial F, Kopp I, Bernardy K (2008) Methodische Grundlagen für die Entwicklung der Leitlinienempfehlungen (Methodenreport). Schmerz 22, im Druck
38. Hawley DJ, Wolfe F, Cathey MA (1988) Pain, functional disability, and psychological status: a 12-month study of severity in fibromyalgia. J Rheumatol 15: 1551-1556
39. Henningsen P, Zimmermann T, Sattel H (2003) Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med 65: 528-533
40. Henningsen P, Derra C, Turp JC, Häuser W (2004) Functional somatic pain syndromes: summary of hypotheses of their overlap and etiology. Schmerz 18: 136-140
41. Henningsen P, Zipfel S, Herzog W (2007) Management of functional somatic syndromes. Lancet 369: 946-955
42. Henriksson CM, Lindberg GM, Gerdle B (2005) Women with fibromyalgia: work and rehabilitation. Disabil Rehabil 27: 685-695
43. Hiller W, Rief W, Brahler E (2006) Somatization in the population: from mild bodily misperceptions to disabling symptoms. Soc Psychiatry Psychiatr Epidemiol 41: 704-712
44. Hueppe A, Brockow T, Raspe H (2004) Chronic widespread pain and tender points in low back pain: a population-based study. Z Rheumatol 63: 76-83
45. Hughes G, Martinez C, Myon E et al. (2006) The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum 54: 177-183
46. Jaeckel WH, Traber U, Gerdes N (2004) Stationäre Rehabilitation bei Fibromyalgie-Patientlnnen: Konzept und Ergebnisse. Akt Rheumatol 29: 270-275
47. Kato K, Sullivan PF, Evengard B, Pedersen NL (2006) Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med 166: 1649-1654
48. Katz RS, Wolfe F, Michaud K (2006) Fibromyalgia diagnosis: a comparison of clinical, survey, and American College of Rheumatology criteria. Arthritis Rheum 54: 169-176
49. Kennedy M, Felson DT (1996) A prospective long-term study of fibromyalgia syndrome. Arthritis Rheum 39: 682-685
50. Kersh BC, Bradley LA, Alarcon GS et al. (2001) Psychosocial and health status variables independently predict health care seeking in fibromyalgia. Arthritis Rheum 45: 362-371
51. Kivimäki M, Leino-Arjas P, Kaila-Kangas L et al. (2007) Increased sickness absence among employees with fibromyalgia. Ann Rheum Dis 66: 65-69
52. Kohlmann T (2003) Muskuloskelettale Schmerzen in der Bevölkerung. Schmerz 17: 405-411
53. Kroenke K, Mangelsdorff AD (1989) Common symptoms in ambulatory care: incidence, evaluation, therapy and outcome. Am J Med 82: 262
54. Kroenke K, Rosmalen JG (2006a) Symptoms, syndromes, and the value of psychiatric diagnostics in patients who have functional somatic disorders. Med Clin North Am 90: 603-626
55. Kroenke K (2006b) Physical symptom disorder: a simpler diagnostic category for somatization-spectrum conditions. J Psychosom Res 60: 335-339
56. Lappossy E, Maleitzke E, Hrycai P et al. (1993) Der Langzeitverlauf der generalisierten Tendomyopathie (Fibromyalgie), eine retrospective Unrersuchung. Akt Rheumatol 18: 93-98
57. Ledingham J, Doherty S, Doherty M (1993) Primary fibromyalgia syndrome-an outcome study. Br J Rheumatol 32: 139-142
58. Lindgren H, Bergman S (2005) The use and diagnostic yield of radiology in subjects with longstanding musculoskeletal pain - an eight year follow up. BMC Musculoskeletal Disord 6: 53
59. Longstreth GF, Thompson WG, Chey WD et al. (2006) Functional bowel disorders. Gastroenterology 130: 1480-1491
60. Lundberg G, Gerdle B (2002) Tender point scores and their relations to signs of mobility, symptoms, and disability in female home care personnel and the prevalence of fibromyalgia syndrome. J Rheumatol 29: 603-613
61. MacFarlane GJ, Thomas E, Papageorgiou AC et al. (1996) The natural history of chronic pain in the community: a better prognosis than in the clinic? J Rheumatol 23: 1617-1620
62. Mease PJ, Clauw DJ, Arnold LM et al. (2005) Fibromyalgia syndrome. J Rheumatol 32: 2270-2277
63. McBeth J, Macfarlane GJ, Benjamin S et al. (1999) The association between tender points, psychological distress, and adverse childhood experiences: a community based study. Arthritis Rheum 42: 1397-1404
64. Merskey H, Bogduk N (1994) Classification of chronic pain. IASP Press, Seattle
65. Müller A, Hartmann M, Eich W (2000) Health care utilization in patients with fibromyalgia syndrome (FMS). Schmerz 14: 77-83
66. Müller W, Stratz T (2004) Ist die Fibromyalgie eine Krankheit? - Pro. Dtsch Med Wochenschr 129: 1336
67. Nicassio PM, Weisman MH, Schuman C, Young CW (2000) The role of generalized pain and pain behavior in tender point scores in fibromyalgia. J Rheumatol 27: 1056-1062
68. Nöller V, Sprott H (2003) Prospective epidemiological observations on the course of the disease in fibromyalgia patients. J Negat Results Biomed 23: 4
69. Pamuk ON, Yethil Y, Cakir N (2006) Factors that affect the number of tender points in fibromyalgia and chronic widespread pain patients who did not meet the ACR 1990 criteria for fibromyalgia: are tender points a reflection of neuropathic pain? Semin Arthritis Rheum 36: 130-134
70. Papageorgiou AC, Silman AJ, Macfarlane GJ (2002) Chronic widespread pain in the population: a seven year follow up study. Ann Rheum Dis 61: 1071-1074
71. Petzke F, Gracely RH, Park KM et al. (2003) What do tender points measure? Influence of distress on 4 measures of tenderness. J Rheumatol 30: 567-574
72. Poyhia R, Da Costa D, Fitzcharles MA (2001) Pain and pain relief in fibromyalgia patients followed for three years. Arthritis Rheum 45: 355-361
73. Raphael KG, Janal MN, Nayak S et al. (Jahreszahl fehlt) Familial aggregation of depression in fibromyalgia: a community-based test of alternate hypotheses. Pain 110: 449-460
74. Raymond MC, Brown JB (2000) Experience of fibromyalgia. Qualitative study. Can Fam Physician 46: 1100-1106
75. Resine S, Fifield J, Walsh S, Dauser D (2004) Employment and quality of life outcomes among women with fibromyalgia compared to healthy controls. Women Health 39: 1-19
76. Rief W, Isaac M (2007) Are somatoform disorders.,mental disorders"? A contribution to the current debate. Curr Opin Psychiatry 20: 143-146
77. Robinson RL, Birnbaum HG, Morley MA et al. (2004) Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently. J Rheumatol 31: 1621-1629
78. Ruiz Moral R, Munoz Alamo M, Perula de Torres L, Aguayo Galeote M (1997) Biopsychosocial features of patients with widespread chronic musculoskeletal pain in family medicine clinics. Fam Pract 14: 242-248
79. Schochat T, Raspe H (2003) Elements of fibromyalgia in an open population. Rheumatology (Oxford) 42: 829-835
80. Suarez-Almazor ME, Gonzalez-Lopez L, Gamez-Nava JI et al. (1998) Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians. J Rheumatol 25: 1980-1985
81. Thieme K, Turk DC, Flor H (2004) Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med 66: 837-844
82. Topbas M, Cakirbay H, Gulec H et al. (2005) The prevalence of fibromyalgia in women aged 20-64 in Turkey. Scand J Rheumatol 34: 140-144
83. Tunks E, McCain GA, Hart LE et al. (1995) The reliability of examination for tenderness in patients with myofascial pain, chronic fibromyalgia and controls. J Rheumatol 22: 944-952
84. Turk DC, Flor H (1989) Primary fibromyalgia is greater than tender points: toward a multiaxial taxonomy. J Rheumatol 19 [suppl]: 80-86
85. Walen HR, Cronan PA, Bigatti SM (2001) Factors associated with healthcare costs in women with fibromyalgia. Am J Manag Care 25: SP39-SP47
86. Walen H, Cronan T, Serber E et al. (2002) Subgroups of fibromyalgia patients: evidence for heterogeneity and an examination of differential effects following a community-based intervention. J Musculoskeletal Pain 10: 9-32
87. Weir PT, Harlan GA, Nkoy FL et al. (2006) The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th revision codes. J Clin Rheumatol 12: 124-128
88. Wessely S, Nimnuan C, Sharpe M (1999) Functional somatic syndromes: one or many? Lancet 354: 936-939
89. White KP, Speechley M, Harth M, Ostbye T (1999) Comparing self-reported function and work disability in 100 community cases of fibromyalgia snydrom versus controls in London, Ontario: the London Fibromyalgia Epidemiology Study. Arthritis Rheum 42: 76-83
90. White KP, Harth M, Speechley M, Ostbye T (2000) A general population study of fibromyalgia tender points in noninstitutionalized adults with chronic widespread pain. J Rheumatol 27: 2677-2682
91. White KP, Nielson WR, Harth M et al. (2002a) Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample. J Rheumatol 29: 588-594
92. White KP, Nielson WR, Harth M et al. (2002b) Does the label.,fibromyalgia" alter health status, function, and health service utilization? A prospective, within-group comparison in a community cohort of adults with chronic widespread pain. Arthritis Rheum 15(47): 260-265
93. Wigers H (1994) Fibromyalgia outcome: the predictive values of symptom duration, physical activity, disability pension, and critical life events-a 4.5 year prospective study. J Psychosom Res 41: 235-243
94. Wolfe F, Srnythe HA, Yunus MB et al. (1990) The American College of Rheumatology 1 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 33: 160-172
95. Wolfe F (1997a) The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 56: 268-271
96. Wolfe F, Anderson J, Harkness D et al. (1997b) A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 40: 1560-1570
97. Wolfe F (1998) What use are fibromyalgia control points? J Rheumatol 25: 546-550
98. Wolfe F (2003) Stop using the American College of Rheumatology criteria in the clinic. J Rheumatol 30: 1671-1672
99. Zonana-Nacach A, Alarcón GS, Reveille JD et al. (1998) Clinical features of ANA-positive and ANA-negative patients with fibromyalgia. J Clin Rheumatol 4: 52-56